The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHZD.L Regulatory News (HZD)

  • There is currently no data for HZD

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Confidential submission of Form F-1 to SEC

4 Feb 2020 07:00

RNS Number : 8287B
Horizon Discovery Group plc
04 February 2020
 

 

 

Horizon Discovery Group plc

 

Confidential submission of Form F-1 to SEC relating to

proposed U.S. public offering

 

Cambridge, UK, 4 February 2020: Horizon Discovery Group plc (LSE: HZD) ("Horizon" "the Group" or "the Company") today announces that it has confidentially submitted a draft registration statement on Form F-1 with the Securities and Exchange Commission (the "SEC") relating to the proposed initial U.S. public offering of American depositary shares ("American Depositary Shares") representing its ordinary shares (the "Offering"). The number of American Depositary Shares to be offered and the price range for the proposed Offering have not yet been determined. Horizon expects to use the proceeds of the Offering for general corporate purposes. The Offering is expected to commence after the SEC completes its review process, subject to market and other conditions, and shareholders and potential investors should note that the potential Offering may or may not proceed.

This news release is being made pursuant to and in accordance with Rule 135 under the Securities Act of 1933, as amended, and does not constitute an offer to sell or the solicitation of an offer to buy securities, and shall not constitute an offer, solicitation or sale in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of that jurisdiction.

Ends

For further information from Horizon Discovery Group plc, please contact:

Horizon Discovery Group plc

Terry Pizzie, Chief Executive Officer

Jayesh Pankhania, Chief Financial Officer

Jon Davies, Head of Investor Relations

Tel: +44 (0) 1223 655 580

 

Numis Securities Limited (Broker and NOMAD)

Freddie Barnfield / Duncan Monteith

Tel: +44 (0) 207 260 1000

 

Consilium Strategic Communications (Financial Media and Investor Relations)

Mary-Jane Elliott / Matthew Neal / Melissa Gardiner

Tel: +44 (0) 20 3709 5700

Email: horizon@consilium-comms.com

 

Westwicke, an ICR Company (US Investor Relations)

Stephanie Carrington

Tel. +1 646-277-1282

Email: horizondiscovery@icrinc.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCUOAURRKUURUR
Date   Source Headline
18th Apr 20167:00 amRNSChange of Adviser
7th Apr 20167:00 amRNSNotice of Results
24th Mar 201612:29 pmRNSAdditional Listing
24th Mar 20168:54 amRNSAdditional Listing
15th Mar 20167:00 amRNSHorizon Discovery hosts symposium on gene editing
2nd Mar 20167:00 amRNSHorizon Discovery Group forms Immuno-oncology JV
26th Jan 20164:04 pmRNSHolding(s) in Company
22nd Jan 20161:21 pmRNSHolding(s) in Company
18th Jan 20167:00 amRNSTrading Update
15th Jan 20164:14 pmRNSAdditional Listing
12th Jan 201610:09 amRNSAdditional Listing
17th Dec 20159:52 amRNSDirector/PDMR Shareholding
11th Dec 20159:23 amRNSAdditional Listing
25th Nov 20157:00 amRNSThree diagnostic agreements worth an initial $3.3m
13th Nov 20157:00 amRNSDirector Dealings
12th Nov 20151:30 pmRNSBoard Change
12th Nov 20157:00 amRNSHolding(s) in Company
12th Nov 20157:00 amRNSHolding(s) in Company
6th Nov 20153:51 pmRNSDirector/PDMR Shareholding
29th Oct 20157:00 amRNSTotal Voting Rights
28th Oct 20157:00 amRNSNew E-Commerce Platform and UK Headquarters
21st Oct 20158:48 amRNSAdditional Listing
15th Oct 20155:44 pmRNSGrant of options under Long Term Incentive Plan
7th Oct 20154:00 pmRNSIssue of Equity
7th Oct 20157:00 amRNSIn-licensing agreement with Servier
22nd Sep 20157:00 amRNSHalf Yearly Report
18th Sep 201510:17 amRNSAdditional Listing
16th Sep 20157:00 amRNSCell Line Licensing Agreement with LakePharma Inc
9th Sep 20157:00 amRNSHZD & Abcam plc Sign License & Supply Agreement
3rd Sep 20157:00 amRNSCancer Research Collaboration with Redx Pharma
3rd Sep 20157:00 amRNSCancer Research Collaboration
1st Sep 201511:49 amRNSAdditional Listing
1st Sep 20157:04 amRNSNotice of Interim Results
27th Jul 20157:00 amRNSHZD To Invest c£10M In Cancer R&D
20th Jul 20157:00 amRNSTrading update
17th Jul 201512:34 pmRNSAdditional Listing
19th Jun 201511:28 amRNSResult of AGM
26th May 20154:46 pmRNS2014 Annual Report and Accounts & AGM Notification
22nd May 20153:28 pmRNSHolding(s) in Company
21st May 20156:04 pmRNSHolding(s) in Company
18th May 201511:50 amRNSResult of General Meeting and Issue of Equity
14th May 20157:00 amRNSDirectorate Change
5th May 20157:01 amRNSCorrection to Results of Placing
1st May 20154:15 pmRNSResults of Placing
1st May 201511:08 amRNSProposed placing and Notice of General Meeting
23rd Apr 20157:00 amRNSHORIZON AND TRANSGENOMIC SIGN OEM AGREEMENT
20th Apr 20157:00 amRNSHorizon & Thermo Fisher Scientific Sign Agreement
14th Apr 20157:07 amRNSPreliminary Results
10th Apr 20153:30 pmRNSAdditional Listing
27th Mar 20158:29 amRNSAdditional Listing

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.